Pre-existing maternal disease Flashcards

1
Q

Define Chronic hypertension

A

Chronic hypertension is high blood pressure that exists before 20 weeks gestation and is longstanding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How common is chronic hypertension? In who is it more common?

A

5% of pregnancies.
More common in older and obese women

Positive FHx or hx of increased BP when taking COCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes of hypertension?

A
  • Primary HTN = most common cause
  • Secondary = associated with obesity, M or renal disease e.g. PCKD, RAS or chronic pyelonephritis
  • Rarer causes = phaeochromocytoma, Cushing’s, cardiac disease and aortic coarctation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features of chronic hypertension?

A
  • HTN increase in late pregnancy
  • May identify fundal changes, renal bruits and radio-femoral delay
  • Proteinuria in patients with renal disease is usually noticed at booking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the complications of chronic hypertension?

A
  • Worsening HTN
  • Increased risk of pre-eclampsia toxicaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the ix for chronic hypertension?

A
  • Identify if secondary HTN
  • 24h urinary catecholamines
  • Look for coexistent disease – renal ultrasound and renal function
  • Identify PET → URATE and quantify proteinuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do we split the management of chronic hypertension?

A
  • Pre-conception
  • Antenatal
  • Intrapartum
  • Postnatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should we advise women of chronic hypertension in the pre-conception period?

A

NICE Guidelines:

  • Offer women with chronic hypertension referral to a specialist in hypertensive disorders of pregnancy to discuss the risks and benefits of treatment
  • Stop antihypertensive treatment in women taking ACE inhibitors, ARBs, thiazide or thiazide-like diuretics if they become pregnant (preferably within 2 working days of notification of pregnancy) and offer alternatives.
    • these increase the risk of congenital abnormalities
    • Instead 1st line: Labetolol , 2nd line: Nifedipine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should we advise women of chronic hypertension in the ante-natal period?

A

NICE Guidelines:

  • Conservative
    • Offer advise on weight management, exercise, healthy eating and lowering the amount of salt in their diet.
  • Medications
    • Continue with existing antihypertensive treatment if safe in pregnancy, or switch to an alternative treatment, unless:
      • sustained systolic blood pressure is less than 110 mmHg or
      • sustained diastolic blood pressure is less than 70 mmHg or
      • the woman has symptomatic hypotension.
    • Offer antihypertensive treatment to pregnant women who have chronic hypertension and who are not already on treatment if they have:
      • sustained systolic blood pressure of 140 mmHg or higher or
      • sustained diastolic blood pressure of 90 mmHg or higher.
    • TARGET = 135/85 mmHg
    • 1st line - Labetalol, 2nd line - Nifedipine, 3rd line - Methyl-dopa
    • Offer low-dose aspirin 75-150 mg OD from 12 weeks gestation till birth
    • Offer placental growth factor (PlGF)-based testing to help rule out pre-eclampsia between 20 weeks and up to 35 weeks of pregnancy, if women with chronic hypertension are suspected of developing pre-eclampsia.
  • Appointments - depends on each pregnancy
    • weekly appointments if hypertension is poorly controlled
    • appointments every 2 to 4 weeks if hypertension is well-controlled.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should we advise women of chronic hypertension in the intrapartum period?

A
  • Do not offer planned early birth before 37 weeks to women with chronic hypertension whose blood pressure is lower than 160/110 mmHg
  • For women with chronic hypertension whose blood pressure is lower than 160/110 mmHg after 37 weeks, with or without antihypertensive treatment, timing of birth and maternal and fetal indications for birth should be agreed between the woman and the senior obstetrician
  • If planned early birth is necessary, offer a course of antenatal corticosteroids and magnesium sulfate if indicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should we advise women of chronic hypertension in the postpartum period?

A
  • In women with chronic hypertension who have given birth, measure blood pressure:
    • daily for the first 2 days after birth
    • at least once between day 3 and day 5 after birth
    • as clinically indicated if antihypertensive treatment is changed after birth.
    • AIM: lower than 140/90 mmHg + continue antihypertensive treatment, if required
    • offer a review of antihypertensive treatment 2 weeks after the birth, with their GP or specialist
  • If a woman has taken methyldopa to treat chronic hypertension during pregnancy, stop within 2 days after the birth and change to an alternative antihypertensive treatment
  • Offer women with chronic hypertension a medical review 6–8 weeks after the birth with their GP or specialist as appropriate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What fetal complications are associated with maternal diabetes?

A
  • Congenital abnormalities are 3-4x more likely in established diabetics
    • Related to periconceptual glucose control
    • Neural tube and cardiac defects
    • Fetal lungs are less developed at any given gestation
  • Increased birthweight
  • 10% preterm labour
  • Polyhydramnios due to macrosomia
  • Shoulder dystocia and birth trauma
  • Fetal compromise, fetal distress and sudden fetal death are more common and related to poor control in the third trimester
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What maternal complications are associated with maternal diabetes?

A

 UTI, wound and endometrial infection more common

 Pre-existing hypertension found in 25% of overt diabetics

 PET more common

 IHD worsens

 CS or instrumental delivery more likely due to fetal compromise and → fetal size

 Diabetic nephropathy associated with poor fetal outcomes

 Diabetic retinopathy often deteriorates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do we think of managing pre-existing diabetes during pregnancy?

A
  • Preconception
  • Antenatal
  • Intrapartum
  • Postnatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should we do in the preconception period of women with diabetes?

A

Advise women with diabetes who are planning to become pregnant:

  • that the risks associated with diabetes in pregnancy will increase the longer they have had diabetes
  • to use contraception until they have good blood glucose control
  • that blood glucose targets, glucose monitoring, medicines for treating diabetes (including insulin regimens) and medicines for complications of diabetes will need to be reviewed before and during pregnancy → agree to some targets
    • T1DM: Waking 5 to 7 mmol/L and pre-meal 4-7 mmol/L
    • HbA1c level below 48 mmol/mol (6.5%) - strongly advice women whose HbA1c level is above 86 mmol/mol (10%) not to get pregnant until their HbA1c level is lower
  • who have a body mass index (BMI) above 27 kg/m2, offer advice on how to lose weight
  • to take folic acid (5 mg/day) until 12 weeks of gestation to reduce the risk of having a baby with a neural tube defect.
  • Offer up to monthly measurement of HbA1c levels for women with diabetes who are planning a pregnancy.
  • Offer blood glucose meters for self-monitoring to women with diabetes who are planning a pregnancy.
  • Offer blood ketone testing strips and a meter to women with type 1 diabetes who are planning a pregnancy, and advise them to test for ketonaemia if they become hyperglycaemic or unwell
  • Adjust medications
    • Advise to stop all glucose-lowering agents except metformin and insulin
  • As early as possible, offer a structured education programme to women with diabetes who are planning a pregnancy
  • For women with diabetes who are seeking preconception care, offer a retinal assessment at their first appointment
  • Offer women with diabetes a renal assessment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What should we do for women with diabetes antenatally?

A

o Arrange contact with joint diabetes and antenatal clinic every 1-2 weeks

o Conservative

Ensure mother is up to date with retinal and renal screening

o Monitoring

T1DM or T2DM or gestational diabetes who are on a multiple daily insulin injection regimen - Capillary blood glucose monitoring should be performed by the patient a min. of 7x/day (upon waking, before each meal, 1hr after each meal + bedtime blood glucose levels)

T2DM or gestational diabetes - fasting and 1-hour post-meal blood glucose levels daily if they are:

  • managing their diabetes with diet and exercise changes alone or
  • taking oral therapy (with or without diet and exercise changes) or single-dose intermediate-acting or long-acting insulin.

• Pre-prandial target = <5.3 mmol/l, 1hr post-prandial target = <7.8 mmol/l Specialist foetal cardiac scan at 19-20 weeks
Serial growth scans + amniotic fluid every 4 weeks from 28-36 weeks
Repeat maternal retinal and renal screening (if abnormal at booking repeat at 16-20 weeks, if normal at booking repeat at 28 weeks)

o Medical
Continue high-dose folic acid 5mg OD until 12 weeks gestation
Low-dose aspirin 75mg OD from 12 weeks gestation
Since insulin resistance increases throughout pregnancy, advise patients to increase their dose of metformin or insulin during the 2nd half of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What should we do in the intrapartum period of women with diabetes?

A

o Organise elective birth between 37+0 – 38+6 weeks (IOL or CS) - if no complications

o Consider delivery before this in the presence of foetal/maternal complications
If antenatal corticosteroids are needed, additional insulin therapy must be given concurrently (to maintain normoglycaemic)

Monitor capillary plasma glucose every hour during labour and birth for women with diabetes, and maintain it between 4 mmol/litre and 7 mmol/litre.

o For women on insulin, commence a sliding scale during labour (aim blood glucose levels between 4-7 mmol/l)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the neonatal care in a baby born from a pregnant mother?

A

o Monitoring

Check neonatal blood glucose within 4 hours of birth (to exclude neonatal hypoglycaemia)

Admit babies of women with diabetes to the neonatal unit if they have:

  • hypoglycaemia associated with abnormal clinical signs
  • respiratory distress
  • signs of cardiac decompensation from congenital heart disease or cardiomyopathy
  • signs of neonatal encephalopathy
  • signs of polycythaemia, and are likely to need partial exchange transfusion
  • need for intravenous fluids
  • need for tube feeding (unless adequate support is available on the postnatal ward)
  • jaundice requiring intense phototherapy and frequent monitoring of bilirubinaemia
  • been born before 34 weeks (or between 34 and 36 weeks, if the initial assessment of the baby and their feeding suggests this is clinically appropriate)

Women with diabetes should feed their babies:

  • as soon as possible after birth (within 30 minutes) and then
  • at frequent intervals (every 2 to 3 hours) until feeding maintains their pre-feed capillary plasma glucose levels at a minimum of 2.0 mmol/litre.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should we do in the postpartum period of women with diabetes?

A

Refer women back to their routine diabetes care arrangements

o Medical
Adjust insulin and metformin doses back to those of pre-pregnancy immediately after birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What physiological changes occur to pregnancy to the thyroid?

A
  • Enlargement of the thyroid
  • increase in T4 and T3
  • Increase in TSH in early pregnancy
  • Iodine clearance is increased during pregnancy
  • Fetal thyroxine starts at week 12 (dependent on mother before)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How common is hypothyroidism in pregnancy?

A

Hypothyroidism (including subclinical hypothyroidism) occurs in 2.5% of pregnant women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the causes of hypothyroidism?

A
  • Autoimmune thyroiditis - eg, Hashimoto’s thyroiditis (also known as Hashimoto’s disease).
  • Radiotherapy or surgery.
  • Congenital.
  • Drugs - eg, lithium, amiodarone.
  • Iodine deficiency.
  • Infiltrative diseases.
  • Pituitary or hypothalamic disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the presentation of hypothyroidism in pregnancy?

A

Often subtle and difficult to distinguish from the symptoms of normal pregnancy.

  • Dry skin with yellowing especially around the eyes.
  • Weakness, tiredness, hoarseness, hair loss, intolerance to cold, constipation, sleep disturbance.
  • Goitre, delayed relaxation of deep tendon reflexes.
  • Anaemia, low T4, raised TSH.
  • In the subclinical form TSH is raised but free T4 and T3 are normal.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is hypothyroidism managed during pregnancy?

A
  • Antenatal
    • Monitoring
      • TFTs should be checked every 2-4 wks (TSH<4mmol/L)
    • Medical
      • Thyroid replacement therapy
      • Adjust dose throughout pregnancy according to TFTs
        • Higher doses often required in 1st trimester
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the post natal management of hypothyroidism?

A
  • Monitor
    • TFTs monitoring at 6-8 weeks postnatal
    • Postpartum thyroiditis management
      • Thyrotoxic phase: propanolol (anti-thyroid drugs are avoided)
      • Hypothyroid phase: thyroxine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the complications associated with hypothyroidism during pregnancy?

A

Untreated or under-treated hypothyroidism in pregnancy can lead to several adverse pregnancy outcomes, including miscarriage, anaemia, small for gestational age and pre-eclampsia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How common is hyperthyroidism during pregnancy?

A

Hyperthyroidism is less common than hypothyroidism, with an approximate incidence during pregnancy of 0.2%

28
Q

What are the causes of hyperthyroidism?

A
  • Graves’ disease.
  • Transient gestational hyperthyroidism.
  • Toxic multinodular goitre.
  • Single toxic adenoma.
  • Subacute thyroiditis.
  • Iodine-induced hyperthyroidism.
  • Struma ovarii.
  • Thyrotrophin receptor activation.
29
Q

What is the presentation of hyperthyroidism in pregnancy?

A
  • Tachycardia.
  • Palpitations.
  • Heat intolerance.
  • Systolic murmur.
  • Bowel disturbance.
  • Failure to gain weight.
  • Emotional upset.

Features of Graves’ disease may also be seen - for example:

  • Eye signs.
  • Tremor.
  • Weight loss.
  • Pretibial myxoedema.
30
Q

What are the complications of hyperthyroidism?

A

Maternal

Fetal/neonatal

31
Q

How do we manage hyperthyroidism in pregnancy?

A
  • Antenatal
    • Monitoring TFTs should be checked every 2-4 weeks to ensure biochemical euthyroidism (TSH <4mmol/L)
  • Medical
    • ONLY in 1st trimester: Propylthiouracil. It crosses the placenta and in high doses may cause foetal goitre and hypothyroidism.
    • For the rest of pregnancy: Carbimazole.
    • Continue carbimazole/propylthiouracil at lowest acceptable doses according to TFTs
      • Safety-net regarding agranulocytosis
      • Radioactive iodine is contraindicated
    • Adjust dose throughout pregnancy according to TFTs
      • Women often require lower doses (and 1/3 are able to stop treatment altogether during pregnancy)
  • Postnatal
  • Monitoring
    • TFTs monitoring at 6-8 weeks postnatal check with GP
32
Q

How common is asthma in pregnancy?

A

~ 10% of pregnancies

33
Q

What is the effect of pregnancy on asthma?

A

⅓ improve asthma

⅓ no change

⅓ deteriorate

34
Q

What are the complications of asthma in pregnancy?

A

elevated risk of hypertension in pregnancy

C-section

Intrauterine growth restriction or low birthweight

35
Q

How do we manage asthma in pregnancy?

A

• Antenatal

o Conservative

Re-educate on inhaler technique, smoking cessation etc.

o Medical

Continue pre-existing asthma treatment regimen as normal

• Intrapartum

o Avoid use of ergometrine (bronchoconstrictor)

o Regional anaesthesia is preferable over general anaesthesia, in the case of C-section

36
Q

What types of cardiac defects do we see in pregnant women?

A
  • Congenital (PDA, VSD, ASD, coarction of the aorta etc.)
  • Acquired: valvular defects, ischaemic heart disease
  • Cardiomyopathies: peripartum cardiomyopathy- new onset cardiomyopathy/ heart failure (last month of pregnancy- 6 months post-partum)
37
Q

How do Mitral valve prolapse, VSD and ASD affect pregnancies

A

No problems

38
Q

How does Pulmonary HTN affect pregnancies?

A

high maternal mortality (40%) → pregnancy contraindicated

39
Q

How does aortic stenosis affect pregnancies?

A

Aortic stenosis → severe disease → inability to increase cardiac output, therefore correct before pregnancy

40
Q

How does mitral valve disease affect pregnancies?

A

Mitral valve disease should be treated before pregnancy

o Stenosis → heart failure in late pregnancy

41
Q

Why are cardiac disease important in pregnancies?

A

40% increase of strain on mother’s heart

42
Q

How would cardiac disease in pregnancy present?

A

SOB, palpitations, orthopnoea (SOB lying flat), chest pain

43
Q

What are the investigations for cardiac abnormalities?

A
  • Cardiac Examination
  • BP, Pulse etc.
  • CXR (rule out causes of SOB)
  • Blood: FBC, U&Es, LFTs
  • Cardiac: ECG and Echo

Foetus- serial USS (over the 9 months) for foetal growth

44
Q

How do we think of managing a patient with cardiac disease during pregnancy?

A
  • Pre-conception
  • Antenatal
  • Intrapartum
  • Postnatal
45
Q

What should we do in the preconception period for cardiac disease?

A
  • Assess Cardiac status, address risk in a joint cardiac/O&G clinic.
  • Counselling for the mother due to increased risk of mortality.

o Adjust medications

Advise to stop all teratogenic drugs (ACEi, ARBs, thiazide diuretics, statins and warfarin)

46
Q

What should we do in the antenatal period for cardiac disease?

A

o Arrange contact with joint cardiac and obstetric clinic (every 2-4 weeks until 20 weeks gestation, every 2 weeks until 24 weeks gestation, and weekly thereafter)

o Monitoring

Maternal echocardiogram at booking and repeat at 28 weeks Specialist foetal cardiac scan at 22 weeks

o Medical

VTE prophylaxis with LWMH SC

47
Q

What should we do in the intrapartum period for cardiac disease?

A
48
Q

What should we do in the postnatal period for cardiac disease?

A

o Monitoring

Transfer to HDU for close monitoring for first 12-48 hours

Arrange obstetric and cardiac F/U

49
Q

What are the complications of cardiac disease in pregnancy?

A
  • Maternal: Progression of disease, VTE, PO and death
  • Foetal: PTL, congenital heart defect chance increased if the mother has one, IUGR
50
Q

How common is epilepsy in pregnancy?

A

Epilepsy is one of the most common neurological conditions in pregnancy, with a prevalence of 0.5–1%

51
Q

What types of seizures do we see in WWE during pregnancy? What effect does it have on the mother and baby?

A
52
Q

What are the risks of congenital malformations in the fetus of pregnant WWE exposed and not exposed to AEDs?

A
  1. WWE who are planning their pregnancy should have a clinician competent in the management of epilepsy take responsibility for sharing decisions around choice and dose of AEDs, based on the risk to the fetus and control of seizures.
  2. WWE should be reassured that most mothers have normal healthy babies and the risk of congenital malformations is low if they are not exposed to AEDs in the periconception period.
  3. Women should be informed that the risk of congenital abnormalities in the fetus is dependent on the type, number and dose of AEDs.
53
Q

What are the long-term neurodevelopmental outcomes of exposure to AEDs and maternal seizure in infants born to WWE?

A

WWE and their partners need to be informed about the possible adverse impact on long-term neurodevelopment of the newborn following in utero exposure to sodium valproate.

Based on limited evidence, in utero exposure to carbamazepine and lamotrigine does not appear to adversely affect neurodevelopment of the offspring. There is very little evidence for levetiracetam and phenytoin. Parents should be informed that evidence on long-term outcomes is based on small numbers of children.

54
Q

To what extent can congenital abnormalities be minimised in WWE?

A
  • All WWE should be advised to take 5 mg/day of folic acid prior to conception and to continue the intake until at least the end of the first trimester to reduce the incidence of major congenital malformation.
  • Pre-pregnancy folic acid 5 mg/day may be helpful in reducing the risk of AED-related cognitive deficits.
  • The lowest effective dose of the most appropriate AED should be used.
  • Exposure to sodium valproate and other AED polytherapy should be minimised by changing the medication prior to conception, as recommended by an epilepsy specialist after a careful evaluation of the potential risks and benefits.
55
Q

Summarise the preconception advice regarding epilepsy?

A
  1. Adjust Medications
    1. Switch to monotherapy - Reduce AEDs to lowest effective dose
    2. Switch to lamotrigine or carbamazepine
    3. Sodium valproate contraindicated
  2. High dose folic acid 5mg OF from pre-conception until 12 wks gestation
56
Q

What is the effect of pregnancy on seizures in WEE?

A

WWE should be informed that two-thirds will not have seizure deterioration in pregnancy.

Pregnant women who have experienced seizures in the year prior to conception require close monitoring for their epilepsy.

57
Q

Summarise the antepartum management of epilepsy.

A
  1. Pregnant WWE should have access to regular planned antenatal care with a designated epilepsy care team.
  2. WWE taking AEDs who become unexpectedly pregnant should be able to discuss therapy with an epilepsy specialist on an urgent basis. It is never recommended to stop or change AEDs abruptly without an informed discussion.
  3. All pregnant WWE should be provided with information about the UK Epilepsy and Pregnancy Register and invited to register
  4. Monitoring
    1. Serial growth scans every 4 weeks from 28 to 36 wees gestation
    2. Routine monitoring of AED levels not recommended
58
Q

What adverse effects and risk should practitioners be conscious of in WWE who may take AEDs?

A

Healthcare professionals should be alert to signs of depression, anxiety and any neuropsychiatric symptoms in mothers exposed to AEDs.

Healthcare professionals need to be aware of the small but significant increase in obstetric risks to WWE and those exposed to AEDs, and to incorporate this in the counselling of women and the planning of management.

WWE - higher risk of:

  • Spontaneous miscarriage
  • antepartum haemorrhage
  • hypertensive disorders
  • IOLs
  • C-sections
  • Preterm
  • PPH

AED - higher risk of:

  • IOLs
  • Fetal growth restriction
  • PPH
59
Q

What is the role of vitamin K in preventing haemorrhagic disease of the newborn and maternal haemorrhage in WWE taking AEDs?

A

All babies born to WWE taking enzyme-inducing AEDs should be offered 1 mg of intramuscular vitamin K to prevent haemorrhagic disease of the newborn.

There is insufficient evidence to recommend routine maternal use of oral vitamin K to prevent haemorrhagic disease of the newborn in WWE taking enzyme-inducing AEDs.

60
Q

What is the intrapartum management of WWE?

A

WWE should be reassured that most will have an uncomplicated labour and delivery.

For WWE at risk of peripartum seizures delivery should be in a consultant-led unit with facilities for one-to-one midwifery care and maternal and neonatal resuscitation.

The diagnosis of epilepsy per se is not an indication for planned caesarean section or induction of labour.

Pregnant WWE should be counselled that the risk of seizures in labour is low.

Adequate analgesia (transcutaneous electrical nerve stimulation, nitrous oxide and refional analgesia) and appropriate care in labour should be provided to minimise risk factors for seizures such as insomnia, stress and dehydration.

Long-acting benzodiazepines such as clobazam can be considered if there is a very high risk of seizures in the peripartum period.

AED intake should be continued during labour. If this cannot be tolerated orally, a parenteral alternative should be administered.

61
Q

What is the optimum management of epileptic seizures in labour?

A

Seizures in labour should be terminated as soon as possible to avoid maternal and fetal hypoxia and fetal acidosis. Benzodiazepines are the drugs of choice.

Continuous fetal monitoring is recommended in women at high risk of a seizure in labour, and following an intrapartum seizure

62
Q

Summarise the postpartum management in WWE?

A
  • The overall chance of seizures during and immediately after delivery is low, it is relatively higher than during pregnancy
  • Continue AEDs (review within 10 days if dose increased during pregnancy)
  • Good support - to ensure that triggers of seizure deterioration such as sleep deprivation, stress and pain are minimised.
  • WWE who are taking AEDs in pregnancy should be encouraged to breastfeed.
  • SAFETY ADVICE
  • restart contraception (consider IUS and IUD if enzyme-inducing AEDs)
63
Q

Define obesity.

A

BMI > 30

64
Q

What presentations are common in obesity in pregnancy?

A
  • Fluid retention: polyhydramnios, heat or kidney or liver failure
  • Presentation: GDM, pre-eclampsia, infections
65
Q

How should we investigate pregnant women who are obese?

A
  • BMI monitoring
  • Bloods: FBC, LFTs, U&Es, cholesterol and OGTT
  • USS: liquor volume, foetal growth scan
  • There is no consensus on optimal gestational weight gain
66
Q

How should we manage pregnant women who are obese?

A
  • Antenatal: 5mg folic acid
  • Conservative: Exercise, diet, vit D supplementation
  • Consider LMWH
  • Consider 150mg aspirin if other RFs for pre-eclampsia present
  • Should be screened for GDM
  • Serial SFH for growth monitoring to detect SGA baby
  • Labour planning: need to assess the risks giving birth by vaginal delivery (consider induction/ C-section)
  • Post-natal: T2DM check